Cantor Fitzgerald Initiates Coverage On Nuvation Bio with Overweight Rating

Benzinga Newsdesk www.benzinga.com Positive 57.8%

Neg 0% Neu 0% Pos 57.8%

Cantor Fitzgerald analyst Li Watsek initiates coverage on Nuvation Bio (NYSE:NUVB) with a Overweight rating.

Comments

No comments yet. Be the first!